Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 2 | 1 | — | — | — | 2 |
Leukemia | D007938 | — | C95 | 1 | 1 | — | — | — | 1 |
Myelodysplastic syndromes | D009190 | — | D46 | 1 | 1 | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Myeloid leukemia | D007951 | — | C92 | 1 | 1 | — | — | — | 1 |
Preleukemia | D011289 | — | — | 1 | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Drug common name | PEMRAMETOSTAT |
INN | pemrametostat |
Description | Pemrametostat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | enzyme inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)N1CCC(Nc2cc(C(=O)NC[C@H](O)CN3CCc4ccccc4C3)ncn2)CC1 |
PDB | — |
CAS-ID | 1616392-22-3 |
RxCUI | — |
ChEMBL ID | CHEMBL4466233 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | VXT8SZ6875 (ChemIDplus, GSRS) |